Compare Home Depot Inc (HD) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs Repligen Corporation Common Stock — how do they compare? Home Depot Inc trades at $296.26 (market cap $293.24B), while Repligen Corporation Common Stock trades at $178.86 (market cap $11.14B). The key difference: Home Depot Inc is far larger — about 26.3× Repligen Corporation Common Stock's market cap, and Home Depot Inc pays a 3.17% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Home Depot Inc for 139 Days and Repligen Corporation Common Stock for 0 Days on average.
| HD | RGEN | |
|---|---|---|
Market Cap | $293.24B | $11.14B |
Volume | 4,521,013 | 1,259,263 |
Sector | Consumer Cyclical | Health |
52-Week High | $391.90 | $194.57 |
52-Week Low | $281.15 | $102.87 |
Typical Hold Time | 139 Days | 0 Days |
Enterprise Value | $353.72B | $11.02B |
Dividend Yield | 3.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $295.51, up 1.68% with strong earnings momentum after beating Q2 2026 EPS estimates. The stock shows bearish technical signals but maintains solid fundamentals with $159.51B revenue and 8.41% net margin. Recent institutional activity shows mixed positioning while analyst consensus remains bullish with a $379.93 price target.
HD offers value with reasonable valuation multiples (P/E 20.57) and consistent profitability, though margin compression and housing market sensitivity pose risks. The 58.73% buy rating from analysts suggests upside potential, but investors should monitor Pro segment performance amid weakening big-ticket demand.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
